BlueRock Therapeutics Compagnie réclamée
BlueRock Therapeutics LP is a clinical stage cell therapy harnessing the power of cell therapy to create a pipeline of new medicines for people suffering from neurological and ophthalmic diseases. Two of our novel investigational cell therapies, bemdaneprocel (BRT-DA01) for the treatment of Parkinson’s disease and OpCT-001 for the treatment of primary photoreceptor diseases are clinical stage programs. BlueRock was founded in 2016 as a joint venture of Versant Ventures and Leaps by Bayer. Our culture is defined by the courage to persist regardless of the challenge, the urgency to transform medicine and deliver hope, integrity guided by mission, and community-mindedness with the understanding that we are all part of something bigger than ourselves.
Lire la suite
Great company to work for! Inspiring mission to urgently bring cell therapy treatments to patients, extremely passionate, knowledgeable and friendly colleagues, and great opportunities to grow professionally!
Quelles sont les meilleures choses à propos de votre équipe?
Highly motivated, high energy, passionate, knowledgeable, friendly
Qu’est-ce qui vous plaît le plus dans l’équipe de direction?
Innovative, strategic, investing in employee development
Qu’est-ce qui est le plus positif à propos de la culture et de l’environnement de votre entreprise?
High energy, very friendly and collaborative
Quelle est la meilleure partie de votre programme de rémunération?
Milestone related bonus compensation packages
Qu’est-ce qui vous rend le plus heureux au travail?
Our moonshot mission to deliver on the promise of cell therapies now
Other Employee Reviews for BlueRock Therapeutics
×